Fidaxomicin Superior To Vancomycin As First-Line Treatment For CDI, Study Finds

Infectious Disease Advisor (6/27, McSwiggin) reports, “Among patients with Clostridioides difficile infection (CDI), fidaxomicin is superior to vancomycin as first-line treatment, according to study results published in The Journal of Infectious Diseases.” In the study, “the primary composite outcome of treatment failure occurred in 8 (9.5%) fidaxomicin recipients and 111 (21.6%) vancomycin recipients.”